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Summary and Implications
Ghrelin is an endogenous ligand for growth hormone
secretagogue receptor (GHS-R) and is predominantly
produced by the stomach and lower amounts in the
hypothalamus and various peripheral tissues. Ghrelin is a
potent stimulator of growth hormone (GH) secretion from
the pituitary in vivo and in vitro. GH secretion from the
pituitary also is controlled by two hypothalamic peptides:
stimulatory GH-releasing hormone (GHRH) and
inhibitory somatostatin-14 (SRIH). GH participates in its
own rhythmic secretion through feedback action on
GHRH and SRIH neurons. The mechanism of action of
GHS is not established. The present study examined the
signal transduction pathways of ghrelin in isolated
porcine somatotropes. The ability of ghrelin to induce an
increase in the intracellular Ca2+ concentration – [Ca2+]i –
somatotropes was examined in dispersed porcine pituitary
cells using a calcium imaging system. Somatotropes were
functionally identified by application of human growth
hormone releasing hormone (hGHRH). Ghrelin increased
the [Ca2+]i in a dose-dependent manner in 98% of the cells
that responded to. In the presence of (D-Lys3)-GHRP-6, a
specific receptor antagonist of GHS-R, the increase in
[Ca2+]i evoked by ghrelin was decreased. Pretreatment of
cultures with somatostatin or neuropeptide Y reduced the
ghrelin-induced increase of [Ca2+]i. The stimulatory effect
of ghrelin on somatotropes was greatly attenuated in low-
calcium saline and blocked by nifedipine, an L-type
calcium channel blocker, suggesting involvement of
calcium channels. In a zero Na+ solution, the stimulatory
effect of ghrelin on somatotropes was decreased,
suggesting that besides calcium channels, sodium
channels are also involved in ghrelin-induced calcium
transients. Either SQ-22536, an adenylyl cyclase
inhibitor, or U73122, a phospholipase C inhibitor,
decreased the stimulatory effects of ghrelin on [Ca2+]i
transiently, indicating the involvement of adenylyl
cyclase-cyclic adenosine monophosphate and
phospholipase C inositol 1,4,5-trisphosphate pathways.
The non-peptidyl GHS, L-692,585 (L-585), induced changes
in [Ca2+]i similar to those observed with ghrelin.  Application
of L-585 after ghrelin did not have additive effects on [Ca2+]i.
Preapplication of L-585 blocked the stimulatory effect of
ghrelin on somatotropes. Our results suggest that the actions
of ghrelin and synthetic GHS closely parallel each other, in a
manner that is consistent with an increase of hormone
secretion. An understanding of the molecular mechanisms by
which ghrelin and GHS modulate GH secretion is of particular
interest in the regulation of GH for muscle accretion and
somatic growth.
Introduction
Growth hormone (GH) secretion from the pituitary gland
is controlled by two hypothalamic peptides:  stimulatory GH-
releasing hormone (GHRH) and inhibitory somatostatin-14
(SRIH). GH participates in its own rhythmic secretion through
feedback action on GHRH and SRIH neurons. Peptidyl and
nonpeptidyl compounds, known as GH secretagogues (GHS),
can also stimulate the GH secretion both in vivo and in vitro.
The mechanism of action of GHS is not fully established.
There is both a direct effect on the anterior pituitary gland and
an indirect effect on the hypothalamus. The direct effect of
GHS on GH secretion is through an interaction with a specific
receptor named GHS-R which is distinct from the GHRH
receptor. The GHS-R, a typical G-protein-coupled seven-
transmembrane receptor, has been cloned in pigs, humans, and
rats.
Ghrelin, an endogenous ligand for GHS-R, is an 28-
amino-acid peptide with an n-octanoyl modification at Ser3
residue that is essential for its biological activity. Ghrelin is
predominantly produced by the stomach, whereas lower
amounts are derived from hypothalamus and various
peripheral tissues. Ghrelin receptors (GHS-R) are widely
distributed, e.g., in pituitary, hypothalamus, stomach, heart,
blood vessels, lung, pancreas, intestine, kidney, adipose tissue,
and immune system. This suggests that ghrelin can have
peripheral and central effects in addition to having a powerful
effect on the secretion of GH. Moreover, ghrelin signals
directly to the hypothalamic regulatory nuclei to control
energy homeostasis and, therefore, might regulate the growth
process in an integrated manner.
Ghrelin has been demonstrated to induce GH secretion
from the pituitary in vivo and in vitro. The effects of ghrelin
exhibit a similar time course for GH release to that of other
GHS. Several studies confirm that the actions of ghrelin and
peptidyl GHS closely parallel each other.
The present study examined intracellular Ca2+
mobilization and the signal transduction pathways of ghrelin
in isolated porcine somatotropes and the interaction between
ghrelin and nonpeptidyl GHS, L-692,585 (L-585) (1).
Materials and Methods
Experimental animals
Yorkshire pigs, raised at the Iowa State University
Animal Nutrition Farm, were used for these experiments.
Animal care and experimental protocols were in
accordance with the guidelines and approval of the Iowa
State University Committee on Animal Care.
Preparation of Cell Cultures
Newborn pigs, 1-8 days of age (n = 26), were
sacrificed and the pituitary glands were immediately
removed and collected in cold sterile EBSS solution
(4°C). Primary cell cultures from neonatal anterior
pituitary gland were established. Tissue from 2 animals
were incubated for 50 min at 37°C in 2 ml of EBSS-
papain solution (1.54 mg/ml) and followed by trypsin
inhibitor solution (1 mg/ml). After being rinsed, once with
EBSS solution and once with DMEM-0.1% BSA
medium, the tissue was mechanically dispersed and the
supernatant containing cells was removed and filtered
through a sterile filter. The cells were plated onto poly-L-
lysine (0.1 mg/ml; 100,000 kD) coated glass coverslips (at
a density of 2 × 105 cells). Cultures were maintained at
37°C in a humidified 5% CO2/95% air atmosphere.
Studies examining the effects of ghrelin on changes in the
intracellular calcium concentrations – [Ca2+]i – in
somatotropes were carried out after 2 days in culture. The
presence of somatotropes was confirmed by
immunocytochemical methods.
Immunocytochemistry Staining
After fixation with 4% paraformaldehyde for 30 min
at room temperature, the cells were incubated for 30 min
in a 50% goat serum solution containing 1% BSA and 100
mM L-lysine to block nonspecific binding and 0.4%
Triton X-100 to permeabilize the membrane. To stain the
somatotropes, cultures of anterior pituitary gland were
incubated with polyclonal antiporcine GH antibody
(dilution 1:50,000). Antibody visualization was
accomplished by using a Vectastain ABC kit (Vector
Laboratories) and the nickel-enhanced 3,3’-
diaminobenzidine method.
Intracellular Calcium Imaging
The effect of secretagogues on [Ca2+]i was evaluated
by ratiometric imaging techniques. The cells were loaded
with fura-2/AM for 40–60 min at 37° C. Coverslips
containing pituitary cells were washed with Hepes-
buffered solution and further incubated for 10 min at 37°
C to allow deesterification of fura-2/AM. All image
processings and analyses were performed using an
Attoflour system (Atto Bioscience; Rockville, Md., USA)
with a Zeiss microscope. Using wavelengths of 340 and
380 nm, fura-2/AM was excited, and the emitted light was
analyzed at 520 nm.
Statistics
For every treatment, sister cultures were used as controls
in order to minimize the effect of variability on individual
responses. Multiple comparisons were carried out by one-way
Anova followed by the Newman-Keuls multiple-comparison
test. Differences were considered statistically significant at p <
0.05.
Results and Discussion
Stimulatory Effect of Ghrelin on [Ca2+]i in Cultured Porcine
Somatotropes
The presence of somatotropes in pituitary cell cultures
was confirmed by immunocytochemical staining with an
antibody raised against GH. GH-immunoreactive cells
comprised 40% of the total pituitary cells in cultures. An
increase in [Ca2+]i above baseline following hGHRH
application functionally identified GH cells. Of the cells that
responded to hGHRH, 98% also responded to 1 µM ghrelin
applied 10 min after the application of hGHRH. Perfusion
application of 1 µM ghrelin for 2 min produced a prompt
transient increase in [Ca2+]i of 57 + 3.0 nM (n = 227; p < 0.01;
mean + standard error; fig. 1a). A similar calcium response
was observed in previous work after treatment of isolated
porcine somatotropes with nonpeptidyl GHS, L-692,585 (L-
585).
The second application of 1 µM ghrelin 30 min after the
first application increased the [Ca2+]i in 75% of the cells that
responded to the first application (fig. 1a). Application of the
nonselective stimulus potassium (50 mM) after hGHRH and
ghrelin resulted in an elevated [Ca2+]i by 93 + 6.2 nM (p <
0.01) in all cells that responded to hGHRH and ghrelin (fig.
1a).
The effect of ghrelin on calcium transient in cultured
porcine somatotropes was dose dependent (fig. 1b).
Receptor Mediation of the Stimulatory Effect of Ghrelin on
[Ca2+]i
To determine whether the effect of ghrelin was receptor
mediated, experiments were performed with (D-Lys3)-GHRP-
6, a specific antagonist of GHS-R. In the presence of (D-
Lys3)-GHRP-6, the increase in [Ca2+]i evoked by ghrelin (1
µM) was delayed for about 100 seconds and decreased as
compared with the response in controls. These results support
the GHS-R, mediating the effect of ghrelin increasing the
[Ca2+]i in cultured porcine somatotropes.
SRIH Decreases the Effect of Ghrelin
Application of SRIH at concentrations of 10 µM
decreased [Ca2+]i from 92 + 3.5 to 69 + 2.5 nM (n = 115; p <
0.01). In the presence of 10 µM SRIH, the increase in [Ca2+]i
evoked by perfusion application of 1 µM ghrelin for 2 min
was decreased (78 + 4.1 nM, n = 121, vs. 48 + 2.7 nM, n =
103; p < 0.01).
NPY Decreases the Effect of Ghrelin
NPY has a role in the regulation of GH secretion, and
thus the ability of ghrelin to evoke changes in [Ca2+]i in
the presence of NPY was examined. In the presence of
NPY, the increase in [Ca2+]i evoked by 1 µM ghrelin for 2
min was decreased as compared with the response in the
control cultures (63 + 3.5 nM, n = 140, vs. 39 + 2.1 nM, n
= 128, p < 0.01). Thus, NPY influenced the stimulatory
effects of ghrelin.
Role of Membrane Depolarization and Calcium Channels
in Ghrelin Effects
The stimulatory effect of ghrelin was significantly
decreased in calcium-depleted saline. In low-Ca2+ HEPES,
only 42% of the cells that responded to hGHRH also
responded to ghrelin. These results suggest that
extracellular calcium has an important role in the effect of
ghrelin on the GH-secretory cells.
To investigate the contribution of voltage-dependent
Ca2+ channels in calcium influx evoked by ghrelin,
experiments were performed in the presence of nifedipine,
an antagonist of the L-type calcium channel. In the
presence of 100 nM nifedipine, 1 µM ghrelin evoked a
response in 90% of the cells (64 of 71) that responded to
hGHRH. The average increase in [Ca2+]i was significantly
smaller (60 + 2.4 vs. 39 + 2.2 nM; p < 0.01), and the
duration of the sustained phase of calcium increase was
brief.
Signal Transduction Pathways, Phospholipase C (PLC),
and Adenylyl Cyclase-Cyclic Adenosine 3’,5’-
Monophosphate (AC-cAMP) Are Activated by Ghrelin
The involvement of intracellular Ca2+ stores in the
action of ghrelin was further investigated in experiments
with U73122, a selective inhibitor of PLC. Pretreatment
of cultures for 10 min with 5 µM U73122 significantly
decreased the effect of 1 µM ghrelin on calcium transient
implying an involvement of the PLC-IP3 pathway in the
ghrelin action.
To determine whether ghrelin activates the cAMP
pathway, cell cultures were pretreated with SQ-22536, an
AC inhibitor. After 10 min of the application of SQ-
22536 at a concentration 100 µM, the amplitude of the
[Ca2+]i increase evoked by 1 µM ghrelin was significantly
decreased suggesting activation of AC by ghrelin.
Results and Discussion
In the present study, we have shown that ghrelin has
a direct, dose-dependent stimulatory effect on the [Ca2+]i
in isolated porcine somatotropes. It is presumed that this
increase in [Ca2+]i evoked by ghrelin is followed by GH
release. Similarly, in previous experiments on isolated
porcine somatotropes with simultaneous measurements of
GH release and calcium transients, we have shown that L-
585, a nonpeptidyl GHS, evoked an increase in [Ca2+]i  that
coincided with the GH release.
The amplitude of the increase in [Ca2+]i evoked by ghrelin
was similar to that with hGHRH, with the latter at the ten-fold
higher concentration. This may suggest that ghrelin is more
potent than GHRH in stimulating a rapid release of GH. There
was no evidence for any heterologous desensitization between
hGHRH and ghrelin.
Somatostatin decreased, but did not abolish the effect of
ghrelin on calcium transient in porcine somatotropes. The
effects of SRIH on somatotropes are mediated either by
inhibiting the cAMP formation or via decreased Ca2+ influx as
a result of an increase in K+ conductance and
hyperpolarization of somatotropes. GHSs, and probably
ghrelin, can behave as functional SRIH antagonists by
inhibiting K+ channels and depolarizing the plasma membrane
of the somatotropes.
It has been suggested that NPY suppresses the release of
GH by reciprocal regulation of GHRH and SRIH neurons.
Indeed, centrally administered NPY inhibited the GH
secretion in pigs. In the present study, pretreatment of cultured
porcine pituitary cells with NPY decreased the effect of
ghrelin on [Ca2+]i.
Depletion of extracellular calcium greatly diminished but
did not completely abolish the stimulatory effect of ghrelin on
porcine somatotropes. The latter suggests that while ghrelin
does mobilize Ca2+ from intracellular stores, Ca2+ influx has
the major contribution to calcium transient. In somatotropes,
the major Ca2+ channels are the voltage-gated T and L types.
Perfusion of porcine cells with nifedipine decreased the effect
of ghrelin. This indicates an involvement of L-type Ca2+
channels in calcium influx induced by ghrelin and that influx
of calcium is a crucial step in the action of ghrelin, as in the
action of L-585.
The stimulatory effect of ghrelin was decreased in a zero
Na+ environment, suggesting that ghrelin can depolarize
somatotropes, at least partially, through sodium channels.
cAMP, protein kinases A and C, and PLC are possible
signaling systems involved in the action of GHS and are likely
involved in the ghrelin action. In our experiments, U73122, a
PLC inhibitor, decreased the effect of ghrelin on calcium
transient, indicating the involvement of the PLC/IP3 pathway
in ghrelin action on porcine somatotropes. Pretreatment of
porcine somatotropes with SQ-22536, an AC inhibitor, also
decreased the stimulatory effect of ghrelin on calcium
transient, implying that the binding of ghrelin to GHS-R
activates AC.
In the present study, we have for the first time
investigated interactions between ghrelin and the nonpeptidyl
GHS, L-585. To examine interactions between ghrelin and L-
585, we applied these agonists either in succession or
simultaneously. L-585 had no additive effect on [Ca2+]i when
applied 10 min after ghrelin. Moreover, the response evoked
by L-585 was almost completely abolished when applied in
the presence of 100 nM ghrelin, a concentration that alone did
not have any effect on [Ca2+]i. The stimulatory effect of
ghrelin was blocked when it was applied during the
plateau phase of the L-585 action.
Simultaneous application of ghrelin and L-585 did
not have additive effects on calcium transient. Indeed, the
change in [Ca2+]i was reduced as compared with either
GHS alone. Together, our experiments with ghrelin and
L-585 indicate antagonistic effects between these two
agonists. Competition between ghrelin and L-585
probably occurs at the GHS-R on somatotropes which
may involve binding to the different but overlapping
domains on the same receptor.
In summary, ghrelin has a direct stimulatory effect on
porcine somatotropes. During the first phase of the
ghrelin-induced calcium transient, activation of different
signal transduction pathways results from calcium
mobilization from internal stores, whereas a second
prolonged phase results from calcium influx as a
consequence of somatotrope depolarization by ghrelin
acting on Na+ and K+ channels and the activation of
calcium channels by acting on different second
messengers.
Fig. 1. Stimulatory effect of ghrelin on the [Ca2+]i in
porcine somatotropes. a Somatotropes were functionally
identified by a 2-min application of 10 µM hGHRH.
Subsequent administration of 1 µM ghrelin evoked an increase
in [Ca2+]i in 98% of the somatotropes. The repeated
administration of ghrelin after 30 min did not have an additive
effect on the [Ca2+]i, increase, suggesting the existence of
homologous desensitization of GHS-R. Application of 50 mM
K+ increased the [Ca2+]i in all cells that responded to hGHRH
and ghrelin. Panels of images of calcium transient were taken
at the time indicated on the time course histogram. b
Application of ghrelin at concentrations of 100 nM, 500 nM,
and 1 µM dose dependently increased the [Ca2+]i in isolated
porcine somatotropes. The application of 500 nM ghrelin for 2
min evoked a smaller response than application of 1 µM
ghrelin in cultures run in parallel (p < 0.01), while the
application of 100 nM ghrelin for 2 min evoked a smaller
response than application of 500 nM ghrelin in cultures run in
parallel (p < 0.05).
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